The Recall Desk
ModerateFDA (Drugs)·D-1086-2015·Announced 2015-06-03

Noven Recalls Daytrana Methylphenidate Patches Due to Defective Delivery System

Noven Pharmaceuticals is recalling 125,340 Daytrana patches because one lot exceeded the mechanical peel specification. The recall is nationwide.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, indicating a theoretical or low-risk hazard.

Plain-English summary

Noven Pharmaceuticals, Inc. is recalling 125,340 Daytrana (methylphenidate transdermal system) patches. The affected product is Lot # 73346, with an expiration date of 03/2015. The patches deliver 30 mg of methylphenidate over 9 hours and are distributed nationwide.

The recall was initiated because one lot exceeded the mechanical peel specification, which is a defect in the delivery system. The source text does not report any illnesses, injuries, or deaths associated with this recall.

Consumers should stop using the affected patches and contact their healthcare provider or pharmacist for further instructions. The recall is classified as FDA Class II.

The recalled product

Product
DAYTRANA (METHYLPHENIDATE)
Brand
DAYTRANA
Manufacturer
Noven Pharmaceuticals, Inc.
Category
Drug — Prescription Drug
Hazard
Affected units
125,340

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 73346
  • Exp 03/2015

Distribution

Distributed nationwide across the United States.

Related recalls

Same brand · DAYTRANA

Same manufacturer · Noven Pharmaceuticals, Inc.

See all →

Same hazard · defective delivery system

See all →